Droxicam, a new oxicam NSAID, has analgesic, antiinflammatory and antipyretic properties similar to other NSAIDs. In addition, its adverse effect profile, particularly in terms of adverse GI events, appears to be better than some other NSAIDs. Newsletter Article 17 February 2013 Pages: 18 - 18
Challenge of optimal management of acute lymphoid leukaemia Newsletter Article 17 February 2013 Pages: 19 - 19
Cisplatin and etoposide induce major gastroduodenal lesions Newsletter Article 17 February 2013 Pages: 20 - 20
Hydrophobicity - an important factor in antifungals Newsletter Article 17 February 2013 Pages: 21 - 21